A new genome-wide polygenic risk score for chronic kidney disease (CKD) that combines APOL1 risk genotypes with polygenic effects was validated in 15 diverse cohorts. The top 2% of the score reproducibly conveyed a threefold higher risk of CKD across all ancestries, a degree of risk that is equivalent to a positive family history of kidney disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957–972 (2019). Discovery GWAS for renal function used to derive the polygenic component of the score for CKD.
Parsa, A. et al. APOL1 risk variants, race, and progression of chronic kidney disease. N. Engl. J. Med. 369, 2183–2196 (2013). Demonstration of the effects of APOL1 on the risk of kidney disease progression.
Wand, H. et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature 591, 211–219 (2021). ClinGen standards for reporting polygenic risk scores in risk-prediction studies.
Shang, N. et al. Medical records-based chronic kidney disease phenotype for clinical care and “big data” observational and genetic studies. NPJ Digit. Med. 4, 70 (2021). Design and validation of a portable and scalable e-phenotype for CKD diagnosis and staging.
Neugut, Y. D. et al. Cases in precision medicine: APOL1 and genetic testing in the evaluation of chronic kidney disease and potential transplant. Ann. Intern. Med. 171, 659–664 (2019). An article from the ‘Cases in Precision Medicine’ series discussing APOL1 testing in the setting of CKD and kidney transplantation.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Khan, A. et al. Genome-wide polygenic score to predict chronic kidney disease across ancestries. Nat. Med. https://doi.org/10.1038/s41591-022-01869-1 (2022).
Rights and permissions
About this article
Cite this article
Cross-ancestry genome-wide polygenic score predicts chronic kidney disease. Nat Med 28, 1355–1356 (2022). https://doi.org/10.1038/s41591-022-01871-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-01871-7
